{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:47:43Z","timestamp":1788392863967,"version":"build-2803163510"},"publisher-location":"Chichester, UK","reference-count":53,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006586.pub3","type":"reference-entry","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T19:08:06Z","timestamp":1239822486000},"source":"Crossref","is-referenced-by-count":25,"title":["Oral contraceptives containing drospirenone for premenstrual syndrome"],"prefix":"10.1002","author":[{"given":"Laureen M","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad A.","family":"Kaptein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans M","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"10.1002\/14651858.CD006586.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel","volume":"5","author":"Foidart","year":"2000","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"key":"10.1002\/14651858.CD006586.pub3-BIB3|cit2","first-page":"27-34; discussi","article-title":"Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder","volume":"7 Suppl 3","author":"Freeman","year":"2002","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"key":"10.1002\/14651858.CD006586.pub3-BIB2|cit3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"Journal of Women's Health & Gender-based Medicine"},{"key":"10.1002\/14651858.CD006586.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1097\/00006250-200604001-00035","article-title":"Determining clinically meaningful benefit in the treatment of premenstrual dysphoric disorder (abstract)","volume":"107","author":"Borenstein","year":"2006","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006586.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2004.07.010","article-title":"A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 \u00b5g on premenstrual symptoms","volume":"71","author":"Sangthawan","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006586.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/ejc.8.1.37.51","article-title":"Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms","volume":"8","author":"Apter","year":"2003","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"key":"10.1002\/14651858.CD006586.pub3-BIB9|cit9","first-page":"35-41; discussi","article-title":"Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being","volume":"7 Suppl 3","author":"Mansour","year":"2002","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"key":"10.1002\/14651858.CD006586.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.contraception.2005.10.016","article-title":"Effect of a combination of ethinylestradiol 30 \u00b5g and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception","volume":"74","author":"Borges","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006586.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2006.05.012","article-title":"Oral contraceptives and premenstrual symptoms: comparison of a 21\/7 and extended regimen","volume":"195","author":"Coffee","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB12|cit12","unstructured":"Joffe H Hall JE Soares CN Gottschall H Cohen LS Oral contraceptive pills to treat premenstrual worsening of depression 158th Annual Meeting of the American Psychiatric Association; 2005 May 21-26; Atlanta, GA 2005"},{"key":"10.1002\/14651858.CD006586.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD006586.pub3-BIB14|cit14","unstructured":"American College of Obstetricians and Gynecologists Premenstrual syndrome ACOG Practice Bulletin 2000"},{"key":"10.1002\/14651858.CD006586.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD006586.pub3-BIB16|cit16","unstructured":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) www.psychiatryonline.com\/dsmLibrary.aspx"},{"key":"10.1002\/14651858.CD006586.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3999(98)00042-7","article-title":"Cognitive therapy for premenstrual syndrome: a controlled trial","volume":"45","author":"Blake","year":"1998","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD006586.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1192\/apt.7.6.469","article-title":"Premenstrual syndrome: an update on definitions, diagnosis and management","volume":"7","author":"Connolly","year":"2001","journal-title":"Advances in Psychiatric Treatment"},{"key":"10.1002\/14651858.CD006586.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD006586.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/9780470693926.ch16","article-title":"Effect measures for meta-analysis of trials with binary outcomes","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD006586.pub3-BIB21|cit21","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD006586.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","article-title":"Daily Record of Severity of Problems (DRSP): reliability and validity","volume":"9","author":"Endicott","year":"2006","journal-title":"Archives of Women's Mental Health"},{"key":"10.1002\/14651858.CD006586.pub3-BIB23|cit23","unstructured":"US Food Drug Administration Drug details. YAZ. Label and approval history http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.DrugDetails"},{"key":"10.1002\/14651858.CD006586.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/13697130500330309","article-title":"Added benefits of drospirenone for compliance","volume":"8 Suppl 3","author":"Foidart","year":"2005","journal-title":"Climacteric"},{"issue":"4","key":"10.1002\/14651858.CD006586.pub3-BIB25|cit25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003415.pub2","article-title":"Progesterone for premenstrual syndrome","author":"Ford","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006586.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2004.09.005","article-title":"Twenty micrograms versus >20 mcg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials","volume":"71","author":"Gallo","year":"2005","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD006586.pub3-BIB27|cit27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003987.pub2","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006586.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/01674820009075612","article-title":"Prevalence of sexual abuse history in a sample of women seeking treatment for premenstrual syndrome","volume":"21","author":"Golding","year":"2000","journal-title":"Journal of Pyschosomatic Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB29|cit29","first-page":"223","article-title":"Assessing the assessment measures for menstrual cycle symptoms. A guide for researchers and clinicians","volume":"52","author":"Haywood","year":"2002","journal-title":"Journal of Pyschosomatic Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB30|cit30","first-page":"9","article-title":"Psychosocial associates of premenstrual symptoms and the moderating role of social support in a community sample","volume":"62","author":"Haywood","year":"2007","journal-title":"Journal of Pyschosomatic Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB31|cit31","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] www.cochrane.dk\/cochrane\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD006586.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/01674820209074672","article-title":"A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder","volume":"23","author":"Hunter","year":"2002","journal-title":"Journal of Pyschosomatic Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.AOG.0000140686.66212.1e","article-title":"Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: A clinical primer for practitioners","volume":"104","author":"Johnson","year":"2004","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB34|cit34","first-page":"359","article-title":"Treatment of premenstrual disorders","volume":"51","author":"Kroll","year":"2006","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD006586.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00737-005-0102-z","article-title":"Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model","volume":"9","author":"Kurshan","year":"2006","journal-title":"Archives of Women's Mental Health"},{"key":"10.1002\/14651858.CD006586.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD006586.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006586.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00006842-196811000-00006","article-title":"The Development of a Menstrual Distress Questionnaire","volume":"30","author":"Moos","year":"1968","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD006586.pub3-BIB39|cit39","first-page":"302","article-title":"Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: The Calendar of Premenstrual Experiences","volume":"76","author":"Mortola","year":"1990","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-0528.1979.tb10582.x","article-title":"Treatment of premenstrual syndrome by spironolactone","volume":"86","author":"O'Brien","year":"1979","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","article-title":"Drospirenone, a progestogen with antimineralocorticoid properties: a short review","volume":"217","author":"Oelkers","year":"2004","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.fertnstert.2003.08.030","article-title":"Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 \u00b5g of ethinyl estradiol","volume":"81","author":"Paoletti","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006586.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1-11; discussio","DOI":"10.1002\/sim.1328","article-title":"ICH E9 guideline 'Statistical principles for clinical trials': a case study","volume":"22","author":"Phillips","year":"2003","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006586.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0306-4530(03)00096-9","article-title":"A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder","volume":"28 Suppl 3","author":"Rapkin","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/01674820309039670","article-title":"Factor structure of the modified Moos Menstrual Distress Questionnaire: assessment of prospectively reported follicular, menstrual and premenstrual symptomatology","volume":"24","author":"Ross","year":"2003","journal-title":"Journal of Psychosomatic Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD006586.pub3-BIB46|cit46","volume-title":"Evidence-based Medicine: How to Practice and Teach EBM","author":"Sackett","year":"2000"},{"key":"10.1002\/14651858.CD006586.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome","volume":"338","author":"Schmidt","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006586.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD006586.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006586.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(02)07882-0","article-title":"Sample size slippages in randomised trials: exclusions and the lost and wayward","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006586.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2005","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD006586.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","article-title":"Treatment of premenstrual syndrome by spironolactone: A double-blind, placebo-controlled study","volume":"74","author":"Wang","year":"1995","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD006586.pub3-BIB53|cit53","first-page":"339","article-title":"Premenstrual disorders. Prevalence, etiology and impact","volume":"51","author":"Winer","year":"2006","journal-title":"Journal of Reproductive Medicine"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006586.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006586.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:01:31Z","timestamp":1628546491000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006586.pub3"}},"subtitle":[],"editor":[{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":53,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006586.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006586.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,4,15]]}}}